About EYENOVATE and Retina Futura at FLORetina
In 2025 the first edition of EYENOVATE was launched: a multidisciplinary forum focused on innovation trends, investment dynamics, and regulatory frameworks shaping the future of ophthalmology. Together with Retina Futura – the program launched in 2024 and dedicated to timely insights from ongoing and upcoming clinical trials – the growing need for continuous updates on emerging solutions was addressed.
The fundamentals and novelties for 2026 are as follows:
Floretina-ICOOR meeting will take place from 3 to 6 December (Thursday to Sunday)
Eyenovate & Retina Futura Clinical Trials will take place on Thursday, 3 December.
The structure of Eyenovate & Retina Futura Clinical Trials 2026 will focus on:
Company lectures delivered by leading Corporate representatives
Clinical Trials results (under the “Retina Futura Clinical Trials” umbrella) presented by MDs
Investors tracks - one dedicated session and involvement in panel discussions
Regulatory perspectives - one dedicated session with the involvement of regulatory bodies
Key assets:
All activities will take place within one location (Fortezza da Basso). EYENOVATE & Retina Futura Clinical Trials will be hosted on the Spadolini Attico (First Floor) from 8:30 a.m. to 6:30 p.m. The FLORetina‑ICOOR Meeting will begin in the afternoon on the Ground Floor.
Exhibition booths will already open on December 3, starting in the morning, and will remain active throughout the entire event on the Ground Floor, ensuring full coverage of both programs.
CHECK OUT THE PRELIMINARY TOPICS OF THE AGENDA
Join us for a unique, multidisciplinary forum with leading industry, investor, and clinical care innovators.
